Welcome to our dedicated page for Aveanna Healthcare Holdings news (Ticker: AVAH), a resource for investors and traders seeking the latest updates and insights on Aveanna Healthcare Holdings stock.
Aveanna Healthcare Holdings Inc. (AVAH) is a leading provider of home healthcare services in the United States. Headquartered in Atlanta, Georgia, Aveanna Healthcare brings together two of the largest providers of pediatric care in the nation - Epic Health Services and PSA Healthcare. The company operates in 33 states with a rapidly growing network of over 200 branch offices. Aveanna Healthcare specializes in delivering comprehensive care to medically fragile patients, both children and adults, through its extensive range of services.
Core Services:
- Private Duty Services (PDS): This segment includes private duty nursing (PDN) and pediatric therapy services. The company provides highly skilled in-home nursing care, raising the standard for clinical expertise in the home care community.
- Home Health & Hospice (HHH): Aveanna offers adult home health and hospice services, providing a high-quality, lower-cost alternative to prolonged hospitalization.
- Medical Solutions (MS): This includes the delivery of enteral nutrition and other medical products to patients, ensuring they receive necessary medical supplies conveniently at home.
In addition to these core services, Aveanna Healthcare offers in-home aide services, respite care, school nurse services, rehabilitation, occupational therapy, and case management services. The company's goal is to provide a seamless healthcare experience by coordinating care among insurers, physicians, hospitals, and other healthcare providers.
Recent Achievements: Aveanna Healthcare has consistently expanded its operations due to overwhelming demand for quality care. The company has also been increasingly offering adult home care services, responding to the growing needs of the aging population.
Partnerships and Collaborations: Aveanna works closely with insurers, hospitals, and other healthcare providers to ensure comprehensive patient care. Its case management services play a crucial role in facilitating communication and coordination among different stakeholders in the healthcare system.
Financial Condition: Aveanna Healthcare derives its revenue primarily from pediatric healthcare services, adult home health and hospice services, and medical solutions. The company continues to focus on expanding its service offerings and improving its financial performance through strategic growth initiatives.
For the latest updates on Aveanna Healthcare Holdings Inc., including performance, events, and developments, please visit their Investor Relations section.
Aveanna Healthcare Holdings reported strong Q3 2024 financial results with revenue of $509.0 million, up 6.5% year-over-year. Gross margin increased 8.4% to $159.7 million, while net loss improved to $42.8 million from $102.4 million in Q3 2023. Adjusted EBITDA grew 32.2% to $47.8 million. The company raised its full-year 2024 guidance, projecting revenue of approximately $2.0 billion and Adjusted EBITDA greater than $168 million. The improved performance was attributed to better payor rates and successful cost reduction efforts.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has appointed Brent Layton as a Class III director and Audit Committee member, effective November 1, 2024. Layton, currently CEO of Sharecare, brings over 20 years of healthcare leadership experience from Centene , where he served as president and COO. In his previous role, he oversaw 31 state Medicaid health plans, Ambetter, and WellCare. The appointment aims to leverage Layton's extensive experience in healthcare policy and managed care organizations to support Aveanna's strategic growth initiatives.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced its participation in the Stephens Annual Investment Conference. The company's management team will be attending virtually on Friday, November 22, 2024. During the conference, Aveanna's executives will be hosting one-on-one meetings with investors.
This virtual attendance at the investment conference provides an opportunity for Aveanna to engage with potential investors and discuss the company's performance, strategies, and future prospects. The one-on-one format allows for more focused and personalized interactions between the company's management and interested investors.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced its schedule for releasing third quarter 2024 financial results. The company will disclose its Q3 results before the market opens on Thursday, November 7, 2024. This will be followed by a conference call at 10:00 a.m. Eastern Time on the same day.
Investors can access the conference call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (international). A replay will be available three hours after the call until November 14, 2024, accessible via 1-844-512-2921 (US) or 1-412-317-6671 (international). The passcode for both the live call and replay is 13748484.
Additionally, a simultaneous webcast of the conference call will be available on the Investor Relations section of Aveanna's website at https://ir.aveanna.com/. The online replay will remain accessible for one week following the call.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced its participation in the Deutsche Bank Annual Leveraged Finance Conference on September 24, 2024, in Scottsdale, AZ. The company's management team will be hosting one-on-one investor meetings during the event.
Aveanna Healthcare, headquartered in Atlanta, Georgia, operates in 33 states across the US. The company offers a wide range of healthcare services for both pediatric and adult patients, including:
- Nursing and rehabilitation services
- Occupational nursing in schools
- Therapy services
- Day treatment centers for medically fragile patients
- Home health and hospice services
- Enteral nutrition delivery
- Case management services
- Respite healthcare services
Aveanna's services aim to provide high-quality, cost-effective alternatives to prolonged hospitalization.
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported strong Q2 2024 results, with revenue increasing 7.0% to $505.0 million and Adjusted EBITDA growing 27.3% to $45.6 million compared to Q2 2023. The company's gross margin increased 1.9% to $158.3 million. Net income was $13.9 million, down from $25.6 million in the prior year period. Based on these positive results, Aveanna has raised its full-year 2024 guidance, projecting revenue greater than $1,985 million and Adjusted EBITDA exceeding $158 million. The company attributes its success to ongoing strategic transformation efforts and enhanced payor partnerships, allowing for expanded care delivery and investment in caregivers.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced the release date for its second quarter 2024 earnings report. The company will disclose its results before the market opens on Thursday, August 8, 2024. Following the release, Aveanna will host a conference call at 10:00 a.m. Eastern Time on the same day.
Investors can access the call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (international). A replay will be available for a week, accessible by dialing 1-844-512-2921 (US) or 1-412-317-6671 (international) with the passcode 13746737. Additionally, a simultaneous webcast will be available on the company's Investor Relations website at https://ir.aveanna.com/.
Aveanna Healthcare Holdings announced its participation in two key healthcare conferences: the UBS Healthcare Services Cape Cod Summit on June 4, 2024, and the Jefferies Global Healthcare Conference on June 5, 2024. The management team will host one-on-one investor meetings at both events, and a fireside chat at the Jefferies conference, which will be webcast live and available for replay. These engagements aim to increase investor visibility and communication.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced first quarter 2024 financial results, showing a revenue of $490.7 million, a 5.2% increase over the prior year, with a net loss of $11.2 million. Adjusted EBITDA increased by 22.5% to $34.9 million. Full year 2024 revenue guidance was raised to over $1,970 million, with Adjusted EBITDA guidance raised to over $150 million. The company emphasized enhancing payor partnerships, investing in caregivers, and expanding care delivery as key factors driving their growth and success.
Aveanna Healthcare Holdings Inc. announced its participation at the Barclays Leveraged Finance Conference in Austin, TX on May 21, 2024. Aveanna's management team will host investor meetings at the conference.
FAQ
What is the current stock price of Aveanna Healthcare Holdings (AVAH)?
What is the market cap of Aveanna Healthcare Holdings (AVAH)?
What services does Aveanna Healthcare provide?
Where is Aveanna Healthcare headquartered?
How many states does Aveanna operate in?
What is the main focus of Aveanna Healthcare's services?
Does Aveanna Healthcare offer services for adults?
What is included in Aveanna's Private Duty Services?
How does Aveanna Healthcare assist in care coordination?
What recent achievements has Aveanna Healthcare made?
What role does Aveanna play in the healthcare system?
Where can I find the latest news about Aveanna Healthcare?
